|
Volumn 36, Issue 7, 2001, Pages 486-491
|
Does ascorbic acid prevent retinopathy during interferon therapy in patients with chronic hepatitis C?
a a a a a a a a a a |
Author keywords
Ascorbic acid; Chronic hepatitis C; Interferon; Retinopathy
|
Indexed keywords
ALPHA INTERFERON;
ASCORBIC ACID;
RECOMBINANT ALPHA2B INTERFERON;
ADULT;
AGED;
ARTICLE;
CONTROLLED STUDY;
DISEASE ASSOCIATION;
DOSE RESPONSE;
EYE FUNDUS;
FEMALE;
HEPATITIS C;
HOSPITAL ADMISSION;
HUMAN;
INCIDENCE;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL SPECIALIST;
PRIORITY JOURNAL;
RANDOMIZATION;
RETINA DISEASE;
RETINA HEMORRHAGE;
RETINOPATHY;
THROMBOCYTE COUNT;
TREATMENT FAILURE;
VISUAL SYSTEM EXAMINATION;
ADULT;
AGED;
ANTIOXIDANTS;
ANTIVIRAL AGENTS;
ASCORBIC ACID;
FEMALE;
HEPATITIS C, CHRONIC;
HUMANS;
INTERFERON-ALPHA;
MALE;
MIDDLE AGED;
RETINAL DEGENERATION;
TREATMENT OUTCOME;
|
EID: 0034885558
PISSN: 09441174
EISSN: None
Source Type: Journal
DOI: 10.1007/s005350170072 Document Type: Article |
Times cited : (8)
|
References (16)
|